Shifting”, “Trojan Horse”, Pathogen-Directed Attack Capability of NanoViricides Platform Technology to Combat AMR ...

Innovative QAP to Support Patient Diagnosis & Analysis of Infected Tissue SamplesMISSISSAUGA, Ontario, Oct. 07, 2024 (GLOBE ...

Detailed price information for Candel Therapeutics Inc (CADL-Q) from The Globe and Mail including charting and trades.

NanoViricides, Inc. (NYSE American.:NNVC) (the “Company”), a clinical stage global leader in broad-spectrum antiviral nanomedicines, reports today that it has now obtained a right of first refusal ...

Assembly Biosciences reported interim results from its Phase 1a study of ABI-5366, a long-acting HSV inhibitor for recurrent ...

The 2024 Lasker–DeBakey Clinical Medical Research Award recognizes Drs. Habener, Mojsov, and Knudsen, who developed GLP-1 medicines that have revolutionized the treatment of obesity.

Jared Holz thought about taking one of the new GLP-1 drugs for weight loss for months ... said about a week into treatment. But the need for needles may soon change. At least a dozen similar ...